We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+10.97%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$11.8B
AUM Growth
+$11.7B
(+70,685%)
Cap. Flow
+$973M
Cap. Flow
% of AUM
8.28%
Top 10 Holdings %
Top 10 Hldgs %
24.41%
Holding
296
New
40
Increased
100
Reduced
97
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$166M |
| 2 |
Amgen
AMGN
|
+$123M |
| 3 |
Autodesk
ADSK
|
+$114M |
| 4 |
UnitedHealth
UNH
|
+$103M |
| 5 |
Merck
MRK
|
+$102M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$78.6M |
| 2 |
Advanced Micro Devices
AMD
|
+$74.2M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$65.6M |
| 4 |
Union Pacific
UNP
|
+$36.4M |
| 5 |
Illumina
ILMN
|
+$26.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.57% |
| 2 | Financials | 22.21% |
| 3 | Healthcare | 21.91% |
| 4 | Communication Services | 9.53% |
| 5 | Industrials | 7.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Rockwell Automation
ROK
$52.3B
| $6.18M | 0.05% |
32,951
| – | – |
|
202
Netflix
NFLX
$303B
| $5.98M | 0.05% |
+159,790
| New | +$5.8M |
|
|
MYOK
203
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $5.95M | 0.05% |
+91,286
| New | +$5.37M |
|
204
East-West Bancorp
EWBC
$18B
| $5.82M | 0.05% |
96,447
+1,650
| +2% | +$106K |
|
205
Roper Technologies
ROP
$38.5B
| $5.75M | 0.05% |
19,430
| – | – |
|
|
ARRY
206
DELISTED
Array Biopharma Inc
ARRY
| $5.32M | 0.05% |
+350,000
| New | +$5.36M |
|
207
Okta
OKTA
$23.7B
| $5.26M | 0.04% |
+74,833
| New | +$4.46M |
|
|
SAGE
208
DELISTED
Sage Therapeutics
SAGE
| $4.94M | 0.04% |
35,000
-40,000
| -53% | -$6.17M |
|
|
209
CALL
Advanced Micro Devices
AMD
$751B
| $4.79M | 0.04% |
15,450
-32,050
| -67% | -$723K |
|
210
Caterpillar
CAT
$387B
| $4.73M | 0.04% |
30,992
| – | – |
|
211
argenx
ARGX
$54.9B
| $4.55M | 0.04% |
+60,000
| New | +$5.32M |
|
212
Chegg
CHGG
$119M
| $4.3M | 0.04% |
151,298
-42,498
| -22% | -$1.27M |
|
213
Golub Capital BDC
GBDC
$3.37B
| $4.21M | 0.04% |
229,076
| – | – |
|
214
New Mountain Finance
NMFC
$666M
| $4.18M | 0.04% |
310,000
| – | – |
|
215
Atara Biotherapeutics
ATRA
$70.3M
| $4.13M | 0.04% |
4,000
| – | – |
|
216
Supernus Pharmaceuticals
SUPN
$2.73B
| $3.78M | 0.03% |
75,000
-175,000
| -70% | -$8.64M |
|
217
Groupon
GRPN
$1.07B
| $3.77M | 0.03% |
+50,000
| New | +$4.4M |
|
|
218
Illumina
ILMN
$29.1B
| $3.61M | 0.03% |
10,121
-82,399
| -89% | -$26.4M |
|
219
Ascendis Pharma A/S
ASND
$16.5B
| $3.54M | 0.03% |
50,000
| – | – |
|
220
Encompass Health
EHC
$11.5B
| $3.4M | 0.03% |
54,805
| – | – |
|
|
ZUO
221
DELISTED
Zuora, Inc.
ZUO
| $3.33M | 0.03% |
+144,232
| New | +$3.85M |
|
|
CERN
222
DELISTED
Cerner Corp
CERN
| $3.3M | 0.03% |
51,211
| – | – |
|
223
InflaRx
IFRX
$247M
| $3.15M | 0.03% |
+91,887
| New | +$2.96M |
|
|
MTLS
224
Materialise
MTLS
$375M
| $3.05M | 0.03% |
221,005
+45,000
| +26% | +$608K |
|
225
Pathward Financial
CASH
$1.87B
| $3M | 0.03% |
109,035
-3,819
| -3% | -$114K |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q3 2018 Portfolio in Review
As of Q3 2018, Polar Capital held 296 positions worth $11.8B, up 70,685% from $16.6M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Polar Capital deployed $973M of net new capital in Q3 2018, opening 40 new positions and adding to 100 existing holdings. Its largest new stake was Johnson & Johnson: 1,250,000 shares worth $173M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $78.6M trimmed.
- Polar Capital's largest Q3 2018 buy was Johnson & Johnson: 1,250,000 shares worth $173M.
- Polar Capital added most to UnitedHealth in Q3 2018, an estimated $103M increase.
- Polar Capital's biggest Q3 2018 reduction was Meta Platforms (Facebook), cutting an estimated $78.6M.
- Polar Capital fully exited Amdocs in Q3 2018, selling an estimated $46.6K.
- Polar Capital's ten largest holdings make up 24% of its $11.8B portfolio in Q3 2018.
- Polar Capital opened 40 new positions and closed 30 in Q3 2018.
- Polar Capital's portfolio value rose 70,685% quarter-over-quarter to $11.8B.
Based on Polar Capital's 13F filing for Q3 2018, filed 14 Nov 2018.